Structures by: Ertan N.
Total: 14
3-(4-Chlorophenyldiazenyl)-1-methyl-2-phenyl-1H-indole
C21H16ClN3
Acta Crystallographica Section E (2006) 62, 6 o2108-o2110
a=8.0836(10)Å b=27.952(4)Å c=30.483(3)Å
α=90.00° β=90.00° γ=90.00°
2-Amino-4-(4'-methoxyphenyl)-1,3-thiazole
C10H10N2OS
Acta Crystallographica Section E (2006) 62, 4 o1609-o1611
a=7.181(2)Å b=7.750(2)Å c=17.994(3)Å
α=90.00° β=90.00° γ=90.00°
N-{4-[(2-Phenyl-1H-indol-3-yl)diazenyl]phenyl}acetamide
C22H18N4O
Acta Crystallographica Section E (2006) 62, 8 o3492-o3494
a=5.996(5)Å b=14.786(5)Å c=20.531(5)Å
α=90° β=90° γ=90°
C12H7N3O2S
C12H7N3O2S
Acta Crystallographica Section C (1997) 53, 1 113-116
a=5.377(1)Å b=10.488(1)Å c=20.320(2)Å
α=77.41(1)° β=86.14(1)° γ=80.28(1)°
1-Methyl-2-phenyl-3-(5-ethyl-1,3,4-thiadiazol-2-yldiazenyl)-1H-indole
C19H17N5S
Acta Crystallographica Section E (2007) 63, 2 o568-o570
a=10.7629(14)Å b=10.0115(8)Å c=16.568(2)Å
α=90.00° β=99.664(6)° γ=90.00°
6-Amino-1,3-dimethyl-5-(4-methylthiazol-2-yldiazenyl)uracil
C10H12N6O2S
Acta Crystallographica Section E (2007) 63, 2 o571-o573
a=9.3604(3)Å b=10.3052(3)Å c=13.2638(5)Å
α=90.00° β=93.391(2)° γ=90.00°
1-Methyl-2-phenyl-1H-indole
C15H13N
Acta Crystallographica Section E (2007) 63, 4 o1963-o1964
a=8.19570(10)Å b=15.8652(3)Å c=17.1653(3)Å
α=90.0° β=90.0° γ=90.0°
C17H15N3O2
C17H15N3O2
Acta Crystallographica Section E (2006) 62, 9 o4130-o4131
a=10.5985(3)Å b=11.2970(2)Å c=12.7652(3)Å
α=90.00° β=107.6970(10)° γ=90.00°
5-[(5-Methylthiazol-2-yl)diazenyl]pyrimidine-2,4,6(1H,3H,5H)-trione
C8H7N5O3S
Acta Crystallographica Section E (2007) 63, 3 o1506-o1508
a=13.092(2)Å b=7.0989(9)Å c=12.913(2)Å
α=90.00° β=116.321(7)° γ=90.00°
3-(5-Methylsulfanyl-1,3,4-thiadiazol-2-yldiazenyl)-1,2-methyl-1H-indole
C13H13N5S2
Acta Crystallographica Section E (2007) 63, 5 o2263-o2264
a=7.2739(2)Å b=13.4818(2)Å c=14.7373(4)Å
α=78.488(4)° β=87.707(5)° γ=85.551(5)°
1,3-Dimethyl-5-(thiazol-2-yldiazenyl)pyrimidine-2,4,6(1H,3H,5H)-trione
C9H9N5O3S
Acta Crystallographica Section E (2006) 62, 12 o5855-o5857
a=15.3047(5)Å b=7.4568(2)Å c=19.5403(5)Å
α=90.00° β=92.152(2)° γ=90.00°
Ethyl [2-(2-phenyl-1H-indol-3-yldiazenyl)-1,3-thiazol-4-yl]acetate
C21H18N4O2S
Acta Crystallographica Section E (2006) 62, 9 o3835-o3837
a=10.61110(10)Å b=10.5040(2)Å c=17.3345(2)Å
α=90.00° β=100.2480(10)° γ=90.00°
3-(5-Ethyl-1,3,4-thiadiazol-2-yldiazenyl)-1,2-dimethyl-1H-indole
C14H15N5S1
Acta Crystallographica Section E (2007) 63, 5 o2265-o2266
a=8.18790(10)Å b=8.2359(2)Å c=10.5343(3)Å
α=92.560(10)° β=96.66(2)° γ=92.31(3)°
C15H10N2O2
C15H10N2O2
Acta Crystallographica Section C (1994) 50, 9 1505-1507
a=4.5230(10)Å b=18.8700(10)Å c=14.2050(10)Å
α=90.° β=91.134(9)° γ=90.°